Sangart, Inc., today announced positive results from its Phase IIa proof-of-concept study of MP4OX (oxygenated pegylated hemoglobin) in severely injured trauma patients with hemorrhagic shock causing lactic acidosis. The study demonstrated that MP4OX, when given in addition to standard of care, was effective at decreasing lactate levels in treated patients. Continue Reading
A study conducted in the UK has established the extent of cardiac adaptation amongst female athletes competing in a number of sports. Continue Reading
The Wall Street Journal: “Faced with mounting debt and looming costs from the new federal health-care law, many local governments are leaving the hospital business, shedding public facilities that can be the caregiver of last resort. … More than a fifth of the nation’s 5,000 hospitals are owned by governments and many are drowning in debt caused by rising health-care costs, a spike in uninsured patients, cuts in Medicare and Medicaid and payments on construction bonds sold in fatter times. Continue Reading
Kaiser Health News tracked a variety of stories over the weekend regarding the new federal health law and getting health coverage, including reports that Congress is poised to weigh changes in the health law’s business purchase requirements and more coverage of young adults lacking health coverage Coverage (8/29). Read Saturday’s and Sunday’s news summaries. Continue Reading
FRC Action PAC, the political action committee connected to Family Research Council Action, praised Alaska’s voters for affirming the right of parents to be notified should their minor daughter seek an abortion. The measure passed by a 55-45 percent margin. Continue Reading
News outlets report on trends in the primary care workforce, including medical homes and concierge medicine. Continue Reading
Free HIV/AIDS tests, other significant tests and medical exams (including physicals) will be available to uninsured residents of the area when the National Association of Free Clinics holds a massive free clinic in New Orleans on Aug. 31 and Sept 1. Continue Reading
Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that the Medanta Independent Ethics Committee (MIEC) at Medanta, The Medicity Institute (Medicity) has approved a treatment program entitled “Use of the Aethlon Hemopurifier in Treating Chronic HCV Infection in Combination with Standard of Care (SOC) Drug Therapy.” Continue Reading
In this Kaiser Health News discussion, KFF’s Jackie Judd talks with Time’s Michael Crowley about recent news during this August recess. Lawmakers are finding the electorate to be quieter on the topic of health care than they were during last summer’s heated town hall meetings. Continue Reading
Plexxikon today announced publication of data from the Phase 1 clinical trial of PLX4032 (RG7204), confirming that treatment of metastatic melanoma patients with the BRAF V600E mutation resulted in significant tumor shrinkage in the majority of patients. Specifically, in the melanoma extension cohort of the study, nearly all patients showed some response; 81 percent of patients had tumor shrinkage of at least 30 percent. Continue Reading
